1. Home
  2. IIIV vs DAWN Comparison

IIIV vs DAWN Comparison

Compare IIIV & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo i3 Verticals Inc.

IIIV

i3 Verticals Inc.

N/A

Current Price

$23.77

Market Cap

642.1M

Sector

Technology

ML Signal

N/A

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

N/A

Current Price

$21.29

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IIIV
DAWN
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
642.1M
2.2B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
IIIV
DAWN
Price
$23.77
$21.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$33.20
$27.61
AVG Volume (30 Days)
392.0K
5.0M
Earning Date
05-06-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
N/A
$158,182,000.00
Revenue This Year
$9.05
$53.52
Revenue Next Year
$8.07
$27.10
P/E Ratio
$1,176.50
N/A
Revenue Growth
N/A
20.60
52 Week Low
$19.89
$5.64
52 Week High
$33.97
$21.23

Technical Indicators

Market Signals
Indicator
IIIV
DAWN
Relative Strength Index (RSI) 57.44 82.81
Support Level $22.51 $6.40
Resistance Level $27.02 N/A
Average True Range (ATR) 0.81 0.71
MACD 0.32 0.99
Stochastic Oscillator 87.65 99.96

Price Performance

Historical Comparison
IIIV
DAWN

About IIIV i3 Verticals Inc.

i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: